Introduction
Plant kingdom represents a rich source of organic compounds, many of which have been in use as agents against several infectious and non-infectious diseases, by the modern medicinal system. The World Health Organization estimated that about an 80% population of developing countries relies on traditional medicines, mostly plant drugs, for their primary health care needs [1, 2] . Particularly in rural India, uses of raw plant products as well as some concoction of plant products in Ayurvedic medicines are sought after to a great proportion, because of cheap availability, and in urban areas too those are increasingly popular for cultural nuances that exist [3] . Further, a large number of phyto-drugs are popular and are preferred to over synthetic ones-a priory, for healthier or rather harmless effects [4] ; almost all the viral infections are always addressed with plant products, as it is known. In ethno-botanical literature of India, several hundreds of plants are known to have the potential to treat many diseases and one of those popular ones is Butea monosperma Lam. (B. monosperma, family Fabaceae [5] (Figure 1) . B. monosperma is traditionally used for the treatment of inflammatory diseases [6] ; it is hepatoprotective [7] , antidiabetic [8] , antihelmintic [9] , it possess antitumor, antiulcer activities and wound healing [10, 11] , leaves possess antimicrobial property [12] [13] [14] , and roots have antispermatic activity [15] . Infections with both Gram-positive (GP) and Gram- negative (GN) bacteria have clinically become intractable, slowly, due to the emergence of multidrug resistant (MDR) strains. Among GP pathogens, strains of Staphylococcus aureus (S. aureus), methicillin resistant S. aureus (MRSA) and vancomycin resistant S. aureus (VRSA), strains of Enterococcus sp. are noteworthy [16] . Moreover, GN bacteria, Acinetobacter sp., Klebsiella pneumoniae (K. pneumoniae), Citrobacter freundii (C. freundii), Escherichia coli (E. coli) and Pseudomonas aeruginosa (P. aeruginosa) are commonly found as pathogens of urinary tract; while Chromobacterium violaceum (C. violaceum), E. coli, K. pneumoniae, Shigella sp, and Salmonella typhi (S. typhi) are pathogens of gastrointestinal tract. Presently, these pathogens are too MDR, recorded in several reports [17] [18] [19] [20] .
Secondly, the resistance of pathogenic bacteria to antibiotics is of high clinical concern. Rather the concept of the control of drug resistance is a matter of clairvoyance for dovetailed antimicrobials today. A suitable epitome is the superbug, multidrug resistant (MDR) S. aureus in the human health domain worldwide, as its different strains or rather incarnations have generated β-lactamase activities in degrading all sorts of penicillin derived antibiotics, in addition to resistance to other groups/generations of antibiotics [21] . Multidrug resistance of Staphylococcus, Pseudomonas, Escherichia and a few more pathogenic bacteria to a wide range of antibiotics has been reported to have been due to non-prudent uses of same antibiotics against infections of food-and pet-animals worldwide [22] , including man. MDR-MRSA strains carry resistance markers for other antibiotics and instances of resistance up to 23 antibiotics in some strains have been reported [23] . The emergence of VRSA is of further concern. Today, the management of the consortium of MDR strains of both GN and GP pathogens has become increasingly difficult because of the β-lactamase production by Staphylococcus, Bacillus, Pseudomonas, Proteus, Klebsiella, Neisseria, Salmonella, Haemophilus and a few more pathogens [20] , and pandrug resistance (PDR, resistance of bacteria to all antibiotics in present use) to different classes of antibiotics in GN ones [24] . Meek appreciation of failures in the control of MDR strains would be inhuman, which generates the impetus on a systematic global search for new drugs from natural resources like plants, worldwide [25, 26] ; chemicals from plants could be chosen for the control in a future crusade against MDR pathogens. Moreover, accumulated ethnomedicinal reports of different countries lend themselves well to the basic information needed for further work on drug-targeting against MDR pathogens [26] .
In the present study, crude leaf extracts of B. monosperma with 5 solvents, petroleum ether, acetone, methanol, ethanol and water (polar to non-polar, extracted by both cold and hot extractions) were used to monitor antibacterial property against 12 clinically isolated MDR bacterial strains.
Materials and methods

Preparation of plant extract
The air-dried powdered leaf material (in 40 g lots) of B. monosperma was extracted with 400 mL volumes of solvents, petroleum ether, acetone, methanol, ethanol and distilled water, separately at 4 °C , in succession. Solvent residues from combined extracts were evaporated by a vacuum rotary evaporator. For hot extraction, in a soxhlet apparatus, a lot of 40 g of powder-mass was placed in the extractor and a volume of 400 mL of a solvent was used during 24 h of soxhletion, till colourless extracts precipitated in the extractor. After filtration, each extract was concentrated by the rotary evaporator. The resultant sticky-mass was dried in a desiccator; the solid mass was stored in a suitable volume of 10% dimethyl sulphoxide (DMSO) with a drop of Tween-80. Cold and hot petroleum ether extracts of B. monosperma were light yellow to yellowish brown in colour. After concentration, the solid physical appearance was seen and the yield amounts were 3.7% in the cold-and 4.2% in the hot-extract. The solid extract was dissolved in a required volume of 10% DMSO and a drop of Tween-80 for a final concentration of 30 mg/mL. Both cold and hot extracts of acetone were brown in colour, it was sticky in appearance after concentration and the yield amounts were 3.12% in the cold and 4.27% in the hot extract. Ethanol extracts were reddish brown in colour and sticky after concentration. The yield amounts were 6 .24% in the cold and 7.90% in the hot extract. Methanol extracts were dark-brown to black in colour and solid, sticky in concentration; after the desiccation amounts were 7.20% in the cold and 8.20% in the hot extracts. Aqueous extracts were black in colour and sticky after the concentration. After desiccation, the amounts were 10 .78% in cold and 10.82% in hot extracts. The stock concentration of each extract was maintained at 30 mg/mL, for further use.
Qualitative test for phytochemicals
Phytochemical screening was carried out to assess the qualitative chemical composition of crude extracts using commonly employed precipitation and colouration procedure to identify the major natural chemical groups, as described earlier [17] . Alkaloids, carbohydrates, flavonoids, glycosides, protein, saponin, starch, sterols and tannins were assessed.
Isolation and identification of pathogenic bacteria
From hospitalized patients of wards and cabins of IMS and Sum Hospital, 12 bacterial strains (four GP species, S. aureus, MRSA, VRSA and Enterococcus sp.; and eight GN bacteria, Acinetobacter sp., K. pneumoniae, C. freundii, E. coli, P. aeruginosa, C. violaceum, Shigella sp. and S. typhi) were isolated. All these 12 strains were identified by standard biochemical tests and were maintained as axenic cultures in suitable media, as described previously [16] [17] [18] [19] . Different clinical samples were collected from patients of wards, cabins, intensive care unit, neonatal care unit in the hospital, and were used for the growth of bacteria in nutrient agar, MacConkey agar, blood agar, eosin methylene blue (EMB) agar, and xylose lysine deoxycholate (XLD) agar. Microbial type culture collection (MTCC) strain of each bacterium was used as the reference control during identification (see Table 1 ). 
Antibiotic sensitivity pattern
All bacterial strains were subjected to antibiotic sensitivity test by Kirby-Bauer's method, using a 4 mm thick MuellerHinton agar medium, as described previously [27] , and results were determined basing upon the standard guidelines [28] . For the control, ciprofloxacin 30 µg/disc was used and it was sensitive to all test bacteria and its inhibition zone range was 17-19 mm.
Antibacterial activity and determination of MIC and MBC
Antibacterial activities of plant-extracts (both cold and hot) were recorded by the agar-well diffusion method, as described previously [16, 17] . The details of methods of determinations of minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) were described previously [18] .
Result
Isolation and biochemical identification of bacteria
Specific colony morphology of each pathogen was noted, for which a corresponding MTCC strain was used, parallely (Table 1 ). For example, colourless smooth, opaque, raised and pinpoint colonies were of Acinetobacter sp. After growth, a single colony was subjected to Gramstaining and basing upon it, other biochemical tests were performed for identification (Table 2 ). For example, E. coli was negative for oxidase, Voges-Proskauer, citrate and urease tests, while bile-esculin was not done; it was positive for catalase, indole, and methyl red, triple sugar iron and nitrate reduction tests. Similarly, the rest bacteria were typified. Four GPs, S. aureus, MRSA, VRSA, Enterococcus sp. and eight GNs, Acinetobacter sp., C. violaceum, C. freundii, E. coli, K. pneumoniae, Proteus sp., P. aeruginosa, and S. typhi were isolated.
Phytochemical analyses
From phytochemical analyses, it was ascertained that saponins and tannin, but not sterol and protein were present in leaf-extracts, obtained with petroleum ether, acetone, ethanol, methanol and water. Alkaloids, carbohydrates, glycosides were present in extracts obtained with petroleum ether, ethanol and water. Starch only was found in extracts obtained with acetone and water; in water extract the maximum number of phyto-constituents and the acetone extract had the least number were noted, and extracts with the rest other solvents had medium levels of phytoconstituents (Table 3) . -(-) 
Antibiotic sensitivity pattern
Antibiotic profile of each bacterial strain was determined using specified antibiotic discs (Table 4) . Acinetobacter sp. S S S S S S R S S S S --C. violaceum
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Third set of antibiotics Le Ac Ctr Azm L Of G Ne Ak Nf Nx Of -R S S R R R R S R S S RAntibiotics (µg/disc): A: ampicillin 30 It was recorded that antibiotics (µg/disc), gentamicin 30 was resistant to seven bacteria and sensitive to two bacteria; norfloxacin 300 was resistant to three and sensitive to six strains; nitrofurantoin 300 was resistant to one and sensitive to eight strains; amikacin 30 was resistant to one and sensitive to eight bacteria; cefotaxime 30 was resistant to seven; imipenem 10 was resistant to seven and sensitive to two; piperacillin/tazobactam 100/10 was resistant to eight and sensitive to one bacterium; gatifloxacin 30 was resistant to four and sensitive to five isolates; ofloxacin 5 was resistant to four and sensitive to five strains; netilmicin 30 was resistant to five and sensitive to four isolates; amoxyclav 30 was recorded as resistant to six and sensitive to three bacteria.
Antibacterial activities
Five pairs of cold and hot leaf-extracts extracted with petroleum ether, acetone, ethanol, methanol and water (non-polar to polar solvents) were screened for antibacterial activity against cited GP bacteria and eight GN bacteria. Hot water extracts had the highest antibacterial activity against Enterococcus sp. (Table 5 ). Leaf-extracts with hot water and ethanol have shown significant antibacterial activity against all bacteria. Leaf-extracts with both cold and hot petroleum ether did not register any antibacterial activity against C. violaceum; and leaf-extract, with ethanol only, had antibacterial activity against Shigella sp.; the maximum size of zone of inhibition had been recorded due to the hot water extract, as 21 mm against Enterococcus, which was 18 mm in the case of ciprofloxacin 30 µg/disc. Detailed information of antibacterial activities of extracts and inhibition zone sizes were recorded (Table 5 ). Acinetobacter sp.
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S. typhi - (-) 13 (13) 14 (14) 15 (15) 15 (15) 17
Shigella sp.
- (-) - (-) - (10) - (-) - (-) 
17
14 (15) 14 (14) 16 (16) 14 (14) 19 (21) 18 S. aureus 14 (15) 12 (12) 14 (14) 14 (14) 16 (16) 19 MRSA 13 (14) 12 (12) 13 (13) 14 (14) 15 (15) 18 VRSA 12 (14) 13 (13) 13 (12) 12 (12) 13 (13) 18 PE: petroleum ether; AC: acetone; EOH: ethanol; MeOH: methanol; in parenthesis, sizes of inhibition zones in hot extracts are given. -: absence of inhibition.
MIC and MBC values
Particular leaf-extracts obtained with different solvents that have shown significant antibacterial activity in the agar-well diffusion method were further used for the determination of MIC With Acinetobacter sp., the minimum MIC in petroleum ether, methanol and water extracts was 2.62 mg/mL, the maximum MIC in petroleum ether extract was 13.30 mg/mL. With Citrobacter sp., the minimum MIC was with petroleum ether, acetone, and methanol extracts as 2.62 mg/mL, and the maximum MIC value was with ethanol and water extracts as 5 .91 mg/mL. With C. violaceum, the lowest MIC value was with acetone extract, 0.52 mg/mL, the highest MIC value was with methanolic and aqueous extracts as 5 .91 mg/mL, but the petroleum-ether-extract was not used for the detection of MIC value. With E. coli, the lowest MIC was with methanolic extract as 5.91 mg/mL, and the highest MIC value with the ethanolic extract was 13.30 mg/mL. With K. pneumoniae, the lowest MIC was with the methanolic extract as 1.16 mg/mL, and the highest MIC value was with the ethanolic extract as 5.91 mg/mL. With P. aeruginosa, the lowest MIC was with petroleum ether extract at 0.52 mg/mL, the highest MIC value was with water extract as 5.91 mg/mL. With S. typhi, the lowest MIC value was with the methanolic extract as 0.52 mg/mL, the highest MIC value was with acetone and water extracts as 5.91 mg/mL. With Shigella sp., MIC value with ethanol and water extracts were 13.3 mg/mL. With Enterococcus sp., minimum MIC value was seen with the water extract as 0.23 mg/mL, and the maximum MIC value was with ethanol and methanol extract as 5.91 mg/mL. With S. 5 .91 mg/mL with the aqueous extract, and the maximum value with the petroleum-ether-extract was 30 .00 mg/mL. With Citrobacter sp., the minimum MBC value was 1.16 mg/mL with the acetone extract, and the maximum value with petroleumether, ethanol and water extracts was 13.30 mg/mL. With C. violaceum, the minimum MBC value was 1.16 mg/mL with acetone and methanolic extracts, the maximum MBC value in methanolic and aqueous extracts was 13.30 mg/mL. With E. coli, the minimum MBC value was 5 .91 mg/mL in ethanolic extract, with the maximum value by ethanolic extract as 30 .00 mg/mL. With K. pneumoniae, the minimum MBC value was 2.62 mg/mL in methanolic extract and the maximum value with petroleum-ether-extract was 30 .00 mg/mL. With P. aeruginosa, the minimum MBC value with petroleum ether extract was 1.16 mg/mL, the maximum MBC value with water extract was 13.30 mg/mL. With S. typhi, the minimum MBC value was with methanolic extract as 1.16 mg/mL, the maximum value with acetone extract was 13.3 mg/mL. With Shigella sp., the MBC value with ethanol and water extracts was 30 .00 mg/mL. With Enterococcus sp. the minimum MBC value with water extract was 0.52 mg/mL, while the maximum MBC value with methanolic extract was 13.30 mg/mL. With S. aureus, the minimum MBC value with acetone extract was 1.16 mg/mL, while the maximum value with petroleumether extract was 13.30 mg/mL. With MRSA, the minimum MBC value with ethanolic extract was 2.62 mg/mL, the maximum value with water extract was 13.30 mg/mL. With VRSA, the minimum MBC value with acetone extract was 2.62 mg/mL, the maximum value with petroleum-ether extract was 30 .00 mg/mL.
Discussion
The presence of tannins, flavonoids, starch, glycosides and carbohydrates in leaf-extracts was established; saponins and tannins were present in all five-extract pairs, whereas sterols and proteins were absent in all extracts; alkaloids, carbohydrates, glycosides were present in three extracts, obtained with petroleum ether, ethanol and water, in this study. As reported, starch was found in leaf-extracts obtained with acetone and water only, whereas, flavones and flavanols [13] , chalcones [29] , isoflavones, triterpenes and pterocarpans [30] , leucocyanidin tetramers [31] , and sterols were recorded with B. monosperma flower-extracts [32, 33] ; the presence of seven flavonoids and glycosides, with two of them (butrin and isobutrin) was recorded [7] . Three glycosides, coreopsin, isocoreopsin and sulfurein were identified, and the remaining two were new and had been assigned the structures-monospermoside and isomonospermoside [33] . Extracts of B. monosperma flowers registered the anticonvulsive activity, due to the presence of a triterpene [34] .
It had been shown that B. monosperma exhibited antifungal activity [35] . Ethanolic bark extract had registered a good control on National Type Culture Collection bacterial strains (drug sensitive strains of S. aureus, Bacillus cereus, P. aeruginosa and E. coli), with the highest sizes of zones of inhibition against the used bacteria, at around 100 mg/mL with the aqueous extract of the plant [36] . Ethanolic extract of B. monosperma bark inhibited the growth of drug sensitive strains of S. aureus, P. aeruginosa and the fungus, Candida. albicans at 400 to 800 mg/mL [37] . Antimicrobial activity of the bark extract with petroleum ether and ethanol in controlling S. aureus, B. subtilis, S. typhimurium and E. coli were the minimum [38] .
In vitro control capacities of the aqueous extract of B. monosperma on E. coli, S. aureus, Enterococcus sp., S. typhi, S. typhimurium and S. flexneri were significant [14] . Antimicrobial activities against extracts of B. monosperma using ethanol, chloroform, petroleum ether seen with E. coli, S. aureus, and B. subtilis were significant. The petroleumether-extract did not inhibit by any bacterium [39] , which finding too corroborated this work. Moreover, wound-healing capacity of B. monosperma had been demonstrated [11] . Antimicrobial activities of the aqueous extract of the plant had been recorded against the destructive enteric pathogen, Vibrio cholerae at the level of 4 mg/mL, with the total gallic acid equivalent at 136 mg [40] .
MRSA strains reported from Nepal were at 40.1% of the total bacterial isolates, and those strains were multiple resistant to trimethoprim/sulfamethoxazole, cephalexin, amikacin, ciprofloxacin and norfloxacin, in addition to the usual penicillin derivatives, but all those were vancomycin sensitive [41] . But the most effective way to prevent clinical crisis due to MRSA has been with daptomycin, nowadays [42, 43] . In Brazil, about 40% to 60% nosocomial infections in urinary and respiratory tracts, boils and surgical wound infections were by MRSA alone, and the presence of mecA gene with those was proved, probably because of such a greater infection prevalence [44] . In a study from Malaysia, it was reported that among 287 pathogens, 52% were GNs with Proteus sp. 25%, P. aeruginosa 25%, K. pneumoniae 15%, E. coli 9%, and the rest 45% were GP bacteria with S. aureus 40%, Group B Streptococci 25% and Enterococcus sp. 9%; antibiograms indicated the susceptibility to imipenem and amikacin in GN and vancomycin in GP bacteria [45] .
Among intracellular pathogens isolated, both S. aureus and Staphylococcus epidermidis were frequently present, the latter species being coagulase-negative Staphylococcus; and S. aureus strains were mostly MRSA. Indeed, S. aureus was not invasive intrinsically, but MRSA was reported as invasive through eye [46] . Further, in a classical study from New York, it was reported that the colonization rate of MRSA was more in intravenous drug abusers [47] .
While analysing the infection dynamics of pathogens, it was obvious that antibiotic sensitive pathogens have a limited capacity of virulence as the employed antibiotic controls them. At several levels, the host defence system also helps the control of pathogens when the later are in a smattering number. Most often than not, an infection from a MDR bacterial strain leads to a disease, particularly when an emulating control-agent/antimicrobial is absent, i.e., the employed antibiotic has been won over by it. Indeed, in the presence of a stress factor-an antibiotic, the bacterial cell undergoes intrinsic or acquired genetic changes via, conjugation/transformation, involving exchanges of resistance markers, exemplified with the mar-locus of E. coli [48] , if at least, the natural selection for the emergence of mutants is slow. Spontaneous mutation in bacteria occurs at the rate, 1 in 10 7 cells usually. Eventually, some drug-resistant mutant predominates with the replacement of all sensitive strains by the resistant strain, the later serving as if a doppelgänger. Since, the emergence of resistant mutants is a self-repetitive process in conditions ideal for pathogens, serial/continual resistant events to a gamut of diverse antibiotics land at the emergence of multidrug resistance in a bacterium, at least in an aged/ immune-compromised body. Indeed, the horizontal transfer of genetic materials from one organism to another appears faster than mutational changes, a phenomenon popularly called as, evolution of quantum leaps, operates naturally [49] . It is because, genes for the drug-resistance mechanism are operative in antibiotic-producing cells, and those are transferred naturally to sensitive strains [50] , as an event of natural selection. Ultimately, antibiotic resistance remains as the clinical determinant of the pathogenesis. Slowly, the use of numbers of antibiotics for the control of infectious diseases in last decades have led to multiple resistances in one cell, the MDR strain of a species, paradigmatically with any of notorious pathogens. As conjectured from retrospective follow-ups, it is clear that older antibiotics slowly became obsolete, by the resistant mechanism. The clinical concern is that antibiotic resistance was reported in several pathogenic bacteria for which, particular antibiotics were never applied. Is this the mechanism of the transformation of a harmless commensal to a perilous MDR pathogen in the present antibiotic era? Not surprisingly, drug resistant bacteria gain the capability of surviving and multiplying under stress conditions. The biological rule, any limiting condition for the majority would be an excellent opportunity for the minority. When in presence of a drug in vivo, all the drug sensitive strains are eliminated and the resistant strain survives, multiplies, and predominates, culminating in a disease. Drug resistant strains and their control by newer antibiotics are leitmotivs in the odyssey of the emergence of MDR and PDR strains of umpteen pathogens in the last 4-5 decades and more. MDR-MRSA is the intractable, ghoulish example rising to a great notoriety of being marked as the superbug of health domain, worldwide [51] .
In conclusion from the recorded data, it could be taken that B. monosperma leaf-extract could be used in treating infectious diseases, caused by the range of tested bacteria, as complementary and alternate medicine, since crude phyto-extracts of the plant could not be breached by MDR pathogenic bacteria. Apothecary would benefit from these findings of the plant for drugs of finesse, i.e., non-microbial antimicrobials in the crusade against MDR pathogens.
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Comments
Background
This paper embodies data on 12 clinically isolated Gram-positive and -negative bacteria and their antibiotic sensitivity patterns. The plant, B. monosperma has folklore report of use in controlling infectious ailments. This work is herewith scientifically confirmed that it could work as complementary/supplementary medicine as antimicrobial for the control of multidrug resistant bacterial strains. MIC and MBC values of the crude extracts gives the idea on its efficacy. Phytochemical analysis is done to access the chemical potentiality of the plant.
Research frontiers
The work was done with clinically isolated MDR pathogens. Hence, this work has overriding importance on similar antimicrobial works, which are reported by others with drug sensitive/ standard strains of bacteria. The results in the present study suggest that B. monosperma leaf-extract could be used in treating diseases caused by a wide range of tested bacteria; water leaf-extract was highly effective against Enterococcus sp. In addition, it was found active against S. typhi. Apothecary could take up this plant for harnessing nonmicrobial antimicrobial after animal toxicity work.
Related reports
Antifungal activity of B. monosperma is described by Lolitha 
Innovations & breakthroughs
The plant B. monosperma could be a potential source of complementary or alternative source of medicine against intractable MDR pathogens. Since antibiotics are no longer effective in controlling these pathogens, results obtained in this study promise new drug(s) that could help the pharmacy world to design a new molecule, which can control these pathogens.
Applications
B. monosperma is a ethnomedicinal plant, which is used by aborigines in many part of India against diarrhoea and other infectious diseases. This study provides a scientific validation of the medicinal properties of this plant. In addition, it provides the details of the phyto-constituents, which may be responsible for the antibacterial activities of the plant.
Peer review
The novelty of the work is that the gamut of bacteria was isolated from clinical samples in a hospital. Due biochemical identification was followed during the procedure, along with standard strains. Search of nonmicrobial antimicrobial is the call of the day for the avalanche of MDR pathogens. Secondly, Indian forest patches are the unique sources of medicinal plants.
